Assel Issabekova

Dr. Assel Issabekova

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2023 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
OMOlga V. Mashkunova
Olga V. Mashkunova
AIAssel Issabekova
Assel Issabekova
ABAigerim Z. Botabekova
Aigerim Z. Botabekova
PNPavel I. Novikov
Pavel I. Novikov
FabryAndersen disease is a genetically determined, progressive disease related to lysosomal storage diseases, linked to the X chromosome, characterized by impaired glycosphingolipid metabolism, due to the deficiency or absence of the enzyme -galactosidase A. Fabry disease is a multisystem disease and is characterized by damage to vital organs kidneys, heart, brain, with the occurrence of complications that cause an unfavorable prognosis. Autoinflammation mechanisms with signs of chronic inflammation are involved in the pathogenesis of the disease. One of the features of Fabry disease are clinical manifestations in the form of arthralgia, fever, skin lesions, which are similar to rheumatological diseases. The article presents a clinical observation of the classical type of Fabry disease with multiple organ manifestation, which required differential diagnosis with rheumatological diseases. Rheumatologists are specialists who are involved in the early diagnosis of Fabry disease, so they should have a high awareness of this sphingolipidosis.

29 August 2023 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
PDF file
AIAssel Issabekova
Assel Issabekova
OMOlga Mashkunova
Olga Mashkunova
Fabry disease is an orphan lysosomal storage disease characterized by progressive organ damage. Considering that the disease is rare, the low awareness of doctors about this pathology leads to late diagnosis of the disease and untimely pathogenetic therapy. Clinical case of late (relative to clinical manifestation) diagnosis of the “classical” phenotype of Fabry Disease in a male patient with cardiac and renal damage and typical early presentations such as neuropathic pain, angiokeratomas, hypohidrosis.

30 June 2026 in Наука и здравоохранение
Verified
Journal Article
Closed access
Nurmukhammad Friba NasrullakyzyNurmukhammad Friba Nasrullakyzy
Nurmukhammad Friba Nasrullakyzy
SZSh.B. Zhangelova
Sh.B. Zhangelova
FRFarida Rustamova
Farida Rustamova
AAAizhan Almukhanova
Aizhan Almukhanova
ASA.B. Sugraliyev
A.B. Sugraliyev
ZSZhanargul Smailova
Zhanargul Smailova
Background:Recurrent ischemic symptoms after coronary artery bypass grafting (CABG) may require repeat percutaneous coronary intervention (PCI). Hypertension is common in coronary artery disease, but its value for predicting repeat revascularization after CABG is uncertain. High residual platelet reactivity (HRPR) may improve risk prediction. Objective: To evaluate the association of arterial hypertension and HRPR with repeat PCI after CABG in patients with recurrent ischemic symptoms. Methods: This retrospective single-center study included 195 patients with prior CABG evaluated for recurrent ischemic symptoms 6-36 months after surgery. Patients were stratified by repeat PCI status. HRPR was assessed using the VerifyNow assay; HRPR was defined as PRU≥208. Clinical and angiographic variables were analyzed using logistic regression. Results:Patients requiring repeat PCI were older and had extensive coronary artery disease and chronic kidney disease. Hypertension prevalence was similar between groups. PRU values were significantly higher in the repeat PCI group (230 vs 145, p<0.001), while HRPR was present in 66.2% of these patients and absent in those without repeat PCI. PRU remained associated with repeat PCI after adjustment. Conclusions: In post-CABG patients with recurrent ischemia, hypertension was not associated with repeat PCI, whereas HRPR showed a strong association with repeat revascularization. Введение:Рецидивирующая ишемия после аортокоронарного шунтирования (АКШ) может потребовать повторного чрескожного коронарного вмешательства (ЧКВ). Роль артериальной гипертензии в прогнозировании повторной реваскуляризации остается неясной, тогда как высокая остаточная реактивность тромбоцитов (ВОРТ) может иметь прогностическое значение. Цель: Оценить ассоциацию артериальной гипертензии и ВОРТ с повторным ЧКВ у пациентов после АКШ с рецидивирующими ишемическими симптомами. Материалы и методы: Ретроспективное одноцентровое исследование включило 195 пациентов после АКШ, обследованных через 6–36 месяцев по поводу рецидивирующей ишемии. Пациенты были разделены по наличию повторного ЧКВ. Реактивность тромбоцитов оценивали методом VerifyNow; HRPRопределяли как PRU ≥208. Данные анализировали с использованием логистической регрессии. Результаты:Пациенты, с повторным ЧКВ, были старше и чаще имели более тяжелое поражение коронарных артерий и хроническую болезнь почек. Частота артериальной гипертензии не различалась между группами. Уровни PRUбыли значительно выше в группе повторного ЧКВ (230 против 145; p<0,001). HRPRвыявлялась у 66,2% пациентов с повторным ЧКВ и отсутствовала в группе без него. PRUсохранял значимую ассоциацию с повторным ЧКВ после корректировки. Выводы: У пациентов после АКШ с рецидивирующей ишемией артериальная гипертензия не связана с повторным ЧКВ, тогда как ВОРТ ассоциируется с повышенным риском повторной реваскуляризации и может иметь прогностическую ценность. Кіріспе: Аортокоронарлық шунттау (АКШ) операциясынан кейін қайталанатын ишемиялық симптомдар қайталама тері арқылы коронарлық араласуды (ТКА) қажет етуі мүмкін. Артериялық гипертензияның қайталама реваскуляризацияны болжаудағы рөлі әлі толық анықталмаған, ал тромбоциттердің жоғары қалдық реактивтілігі (ТЖҚР) болжамдық мәнге ие болуы мүмкін. Мақсаты: АКШ-тан кейін қайталанатын ишемиялық симптомдары бар науқастарда артериялық гипертензия мен ТЖҚР -дың қайталама ТКА-мен байланысын бағалау. Материалдар мен әдістер: Ретроспективті бір орталықты зерттеуге АКШ операциясынан кейін 6–36 ай ішінде қайталанатын ишемияға байланысты тексерілген 195 науқас енгізілді. Науқастар қайталама ТКА-ның болуына қарай топтарға бөлінді. Тромбоциттердің реактивтілігі VerifyNow әдісімен бағаланды; ТЖҚР PRU ≥208 ретінде анықталды. Деректер логистикалық регрессия арқылы талданды. Нәтижелер: Қайталама ЧКВ жасалған науқастар жасы үлкен және коронарлық артериялардың айқын зақымдануы мен созылмалы бүйрек ауруы...

20 November 2025 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Closed access
DADana Akhmentayeva
Dana Akhmentayeva
Zhanar ToktarovaZhanar Toktarova
Zhanar Toktarova
Aigyul IzhanovaAigyul Izhanova
Aigyul Izhanova
Meiramgul TokbulatovaMeiramgul Tokbulatova
Meiramgul Tokbulatova
AIAssel Issabekova
Assel Issabekova
GZG. Kh. Zhansarina
G. Kh. Zhansarina
Introduction . Hyperglycemia is one of the most common pregnancy complications worldwide. The largest proportion of patients are women with gestational diabetes mellitus, followed by pregnant women with previously diagnosed type 1 and type 2 diabetes. Managing such cases is a complex clinical task requiring close cooperation between specialists in various fields. Aim . To analyze the tactics of managing pregnant women with diabetes mellitus to assess predisposing risk factors. Materials and methods. The analysis of modern data was carried out with an emphasis on the role of diabetes mellitus in developing complications during pregnancy. The databases PubMed, Scopus, Web of Science, and eLibrary were used for the analysis. The search was carried out by keywords: gestational diabetes mellitus, pregnancy complications, metabolic disorders, maternal-fetal outcomes, prevention of diabetes in pregnancy. Results . The level of metabolic control at the stage of pregnancy planning has a significant impact on its course and outcome in women with type 1 and type 2 diabetes mellitus. Pre-pregnancy training and professional support of qualified specialists play a key role, often surpassing мнеthe use of modern technologies such as insulin pumps and continuous glucose monitoring systems. Conclusion . Despite the existing methods of prevention and treatment, there remains a need for further study of individualized approaches to the management of pregnant women with metabolic disorders.